Most Lewy body dementia (>80%) and a substantial proportion of all PD cases (>30%) have comorbid Alzheimer’s disease pathologic change, including β-amyloid deposits (neuritic and diffuse plaques) and tau-positive neurofibrillary tangles (46, 50, 51). This evidence concerns the gene MAPT and Parkinson disease.